167 related articles for article (PubMed ID: 12022340)
1. Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children.
Billiau AD; Cornillie F; Wouters C
J Rheumatol; 2002 May; 29(5):1111-4. PubMed ID: 12022340
[No Abstract] [Full Text] [Related]
2. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
[No Abstract] [Full Text] [Related]
3. Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab.
Cannioto Z; Taddio A; Lepore L; Zennaro F
Clin Exp Rheumatol; 2008; 26(4):704-5. PubMed ID: 18799110
[No Abstract] [Full Text] [Related]
4. Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab.
Takezaki S; Okura Y; Ichikawa M; Suzuki D; Ohshima J; Kaneda M; Cho Y; Yamada M; Kawamura N; Iguchi A; Kobayashi I; Ariga T
Mod Rheumatol; 2012 Aug; 22(4):621-4. PubMed ID: 22072226
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.
Mangge H; Heinzl B; Grubbauer HM; El-Shabrawi Y; Schauenstein K
Rheumatol Int; 2003 Sep; 23(5):258-61. PubMed ID: 12687288
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
7. Dosing of biologics in juvenile idiopathic arthritis: is the sky the limit?
Prince FH; Solomon DH
J Rheumatol; 2013 Oct; 40(10):1643-5. PubMed ID: 24085753
[No Abstract] [Full Text] [Related]
8. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Nerome Y; Imanaka H; Nonaka Y; Takei S
Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis.
Oh JY; Kim MK; Wee WR
Jpn J Ophthalmol; 2011 Jan; 55(1):70-1. PubMed ID: 21331698
[No Abstract] [Full Text] [Related]
10. High doses of infliximab in the management of juvenile idiopathic arthritis.
Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
[TBL] [Abstract][Full Text] [Related]
11. A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.
Nerome Y; Imanaka H; Nonaka Y; Tsuru Y; Maeno N; Takezaki T; Mori H; Akaike H; Kubota T; Kawano Y; Takei S
Mod Rheumatol; 2008; 18(2):189-92. PubMed ID: 18273538
[TBL] [Abstract][Full Text] [Related]
12. [Biologic response modifiers for juvenile idiopathic arthritis].
Yokota S
Nihon Rinsho; 2007 Jul; 65(7):1331-5. PubMed ID: 17642252
[TBL] [Abstract][Full Text] [Related]
13. Biologicals in Juvenile Idiopathic Arthritis.
Saini I; Dawman L; Gupta N; Kabra SK
Indian Pediatr; 2016 Mar; 53(3):260-1. PubMed ID: 27029697
[TBL] [Abstract][Full Text] [Related]
14. [Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis].
Shandwick W; Bude S
Kinderkrankenschwester; 2007 Aug; 26(8):335-6. PubMed ID: 17844688
[No Abstract] [Full Text] [Related]
15. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
Fox EJ; Leeder JS; Ye SQ; Becker ML
J Rheumatol; 2013 May; 40(5):741-2. PubMed ID: 23637381
[No Abstract] [Full Text] [Related]
16. Juvenile idiopathic arthritis in the new world of biologics.
Ostring GT; Singh-Grewal D
J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
[TBL] [Abstract][Full Text] [Related]
17. Treatment of anorexia nervosa with TNF-α down-regulating agents.
Bou Khalil R; de Muylder O; Hebborn FL
Eat Weight Disord; 2011 Dec; 16(4):e300. PubMed ID: 22526138
[No Abstract] [Full Text] [Related]
18. Novel treatment options for juvenile idiopathic arthritis.
Steigerwald KA; Ilowite NT
Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis.
Barber J; Sheeran T; Mulherin D
Ann Rheum Dis; 2003 May; 62(5):490-1. PubMed ID: 12695170
[No Abstract] [Full Text] [Related]
20. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
Woo P; Wilkinson N; Prieur AM; Southwood T; Leone V; Livermore P; Wythe H; Thomson D; Kishimoto T
Arthritis Res Ther; 2005; 7(6):R1281-8. PubMed ID: 16277681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
